AlkalizeForHealth
"The doctor of the future will give no medicine, but will interest his patients in the care of the human frame, in diet and in the cause and prevention of disease."
- Thomas Edison Cancer is a political problem more than it is a medical problem. Everything you never wanted to know about the Bush dynasty George Bush: The Unauthorized Biography by Webster G. Tarpley & Anton Chaitkin printed in full on the Internet. Read it for FREE! "No man is good enough to govern another man without that other's consent." - Abraham Lincoln Know your enemy 1, 2, 3, 4 |
Subject: FW: Bush & Monsanto: Today's Pelican Brief
Date: Sun, 18 Mar 2001 20:47:35 -0700
BUSH AND MONSANTO
***************************
The information below is from Robert Cohen, Executive Director of the Dairy Education Board. (http://www.notmilk.com). It shows how the corporations control our government so as to continue to dilute and even poison our food supply in the name of profit.
John Grisham wrote the best selling novel, the Pelican Brief. Julia Roberts and Denzel Washington starred in the blockbuster movie in which two Supreme Court justices are assassinated so that an evil oil billionaire can petition the president to appoint environmentally unfriendly justices to America's highest court. It's all about politics, multi-national firms, and dollars.
Today's Pelican Brief
In 1994, Monsanto Agricultural Company gained approval for their genetically engineered bovine growth hormone. That hormone became the most controversial drug application in the history of America's Food and Drug Administration (FDA). Monsanto's hormone caused cancer in laboratory animals, and was banned in Europe and Canada. Monsanto's genetically engineered crops continue to make headline news throughout the world, and their patented seeds have become the seeds of controversy.
In the 2000 election, Monsanto donated hundreds of thousands of dollars in PAC money and soft money to political candidates. The man receiving the second highest total dollars from Monsanto was Larry Combest (R-TX). He got $2000. Combest is the powerful Chairman of the House Agriculture Committee. Who got the most from Monsanto? The winner of the Monsanto sweepstakes with $10,000 was John Ashcroft (R-MO). Ashcroft will be George Bush's Attorney General.
Follow the Monsanto connection to George Bush's presidency. This brief will be more convincing than Grisham's Pelican Brief. FIRST AND MOST IMPORTANT
Monsanto's lawyer was appointed to the Supreme Court by George Bush, Sr. The deciding swing voter gave the election to George, Jr. That justice: Clarence Thomas, Esq. SECOND
Donald Rumsfeld, Secretary of Defense, was president of Searle Pharmaceuticals, purchased by Monsanto. THIRD
Ann Veneman, Secretary of Agriculture, was on the board of directors of Calgene Pharmaceuticals, purchased by Monsanto. FOURTH
Tommy Thompson, Secretary of Health, was a supporter of Monsanto in Wisconsin. He received $50,000 from biotech firms is his election run, and used state funds to set up a $317 million biotech zone in Wisconsin. FIFTH
Mitch Daniels, Director of the Office of Management and Budget, was the vice president of corporate strategy at Eli Lilly Pharmaceutical Company. Eli Lilly and Monsanto developed the genetically engineered bovine growth hormone. Lilly "owns" the European "franchise." Daniels' presence insures that the bovine growth hormone will one day be approved for use in Europe. SIXTH
The House of Representatives Agriculture Committee Chairman, Larry Combest (R-TX), named Richard Pombo to head Agriculture's dairy, livestock, and poultry sub-committee. Pombo will have enormous power in chairing this committee. In 1994, the Dairy Committee considered a bill that would label milk and milk products containing the genetically engineered hormone. The Dairy Committee stalled the proposed bill until the 1994 elections. When the 1994 session of Congress expired, the bill died. It was never even voted upon. A subsequent investigation of Pombo revealed that he accepted money directly from Monsanto while voting on a bill that impacted Monsanto's future, and the future of biotechnology. SEVENTH
Last, but not least. John Ashcroft, Attorney General. The one man out of 535 members of the House of Representatives and the Senate receiving the greatest amount of financial support from Monsanto. He received five times the amount of money as the congressman finishing second. Where do Americans finish in this stranger than fiction real-life drama?
Last.
***
http://groups.yahoo.com/group/aspartameNM/message/928
revolving door, Monsanto, FDA, EPA: NGIN: Murray 12.23.2 rmforall
http://groups.yahoo.com/group/aspartameNM/message/927
Rumsfeld, 1977 head of Searle Corp., got aspartame FDA approval:
Turner: Murray 12.23.2 rmforall
http://members.tripod.com/~ngin/nginlist.htm
http://members.tripod.com/~ngin/060702a.htm
Norfolk Genetic Information Network 6 July 2002
RUMBLING RUMSFELD/BUSH TANGLED IN WEB OF CORPORATE WRONGDOING? / POLITICAL NOMINATION OF THE MONTH
In this month's Ecologist, the POLITICAL NOMINATION OF THE MONTH goes to Linda Fisher, nominated by the White House for the second-ranking job at the US Environmental Protection Agency. The Ecologist notes that Fisher is head of Monsanto's Washington lobbying office.
This, in fact, is just the latest spin of Washington's famous revolving door. Prior to doing Government and Public Affairs for Monsanto, Fisher worked at the EPA.
Item 3 is a reminder of just how seamless Washington's corporate-state machinery is, while items 1 and 2 point up why in the face of flagrant corporate pressure and malpractice, the US leadership
can always be relied upon to protect the public interest.
1. Rumbling Rumsfeld
2. Bush tangled in web of corporate wrongdoing
3. Welcome to the revolving door
*******
1. Rumbling Rumsfeld
[taken from Welcome to the Spin Machine by Michael Manville
http://www.freezerbox.com/ ]
In 1985 Monsanto purchased G.D. Searle, the chemical company that held the patent to aspartame, the active ingredient in Nutra Sweet. Monsanto was apparently untroubled by aspartame's clouded past, including a 1980 FDA Board of Inquiry, comprised of three independent scientists, which confirmed that it "might induce brain tumors." The FDA had actually banned the drug based on this finding, only to have Searle Chairman Donald Rumsfeld (currently the Secretary of Defense) vow to "call in his markers," to get it approved. On January 21, 1981, the day after Ronald Reagan's inauguration, Searle re-applied to the FDA for approval to use aspartame in food sweetener, and Reagan's new FDA commissioner, Arthur Hayes Hull, Jr., appointed a 5-person Scientific Commission to review the board of inquiry's decision. It soon became clear that the panel would uphold the ban by a 3-2 decision, but Hull then installed a sixth member on the commission, and the vote became deadlocked. He then broke the tie in aspartame's favor. Hull later left the FDA under allegations of impropriety, served briefly as Provost at New York Medical College, and then took a position with Burston-Marsteller, the chief public relations firm for both Monsanto and GD Searle. Since that time he has never spoken publicly about aspartame.
*******
2. [Omitted]
*******
3. Welcome to the revolving door
The "revolving door" - the interplay of personnel that assists the industrial alignment of public service and regulatory authorities - has led to key figures at both the US's FDA and EPA having held important positions at Monsanto, or else doing so shortly after their biotech related regulatory work for the government agency.
An article in The Ecologist's famous 'Monsanto Files' by Jennifer Ferrara, 'Revolving Doors: Monsanto and the Regulators', looked in detail at this issue.
As an instance, Ferrara noted the FDA's approval of Monsanto's genetically engineered cattle drug rBGH which failed to gain approval in either Europe or Canada despite intense lobbying and accusations of malpractice:
"Michael R. Taylor, the FDA's deputy commissioner for policy, wrote the FDA's rBGH labelling guidelines. The guidelines, announced in February 1994, virtually prohibited dairy corporations from making any real distinction between products produced with and without rBGH. To keep rBGH-milk from being "stigmatized" in the marketplace, the FDA announced that labels on non-rBGH products must state that there is no difference between rBGH and the naturally occurring hormone.
In March 1994, Taylor was publicly exposed as a former lawyer for the Monsanto corporation for seven years. While working for Monsanto, Taylor had prepared a memo for the company as to whether or not it would be constitutional for states to erect labelling laws concerning rBGH dairy products. In other words Taylor helped Monsanto figure out whether or not the corporation could sue states or companies that wanted to tell the public that their products were free of Monsanto's drug.
Taylor wasn't the only FDA official involved in rBGI-1 policy who had worked for Monsanto. Margaret Miller, deputy director of the FDA's Office of New Animal Drugs was a former Monsanto research scientist who had worked on Monsanto's rBGH safety studies up until 1989. Suzanne Sechen was a primary reviewer for rBGH in the Office of New Animal Drugs between 1988 and 1990. Before coming to the FDA, she had done research for several Monsanto-funded rBGH studies as a graduate student at Cornell University. Her professor was one of Monsanto's university consultants and a known rBGH promoter. Remarkably. the GAO determined in a 1994 investigation that these officials' former association with the Monsanto corporation did not pose a conflict of interest. But for those concerned about the health and environmental hazards of genetic engineering, the revolving door between the biotechnology industry and federal regulating agencies is a serious cause for concern."
http://www.psrast.org/ecologmons.htm
The following is taken from the Edmonds Institute:
http://www.edmonds-institute.org/door.html
David W. Beier . . .former head of Government Affairs for Genentech, Inc., . . .now chief domestic policy advisor to Al Gore, Vice President of the United States.
Linda J. Fisher . . .former Assistant Administrator of the United States Environmental Protection Agency's Office of Pollution Prevention, Pesticides, and Toxic Substances, . . .now Vice President of Government and Public Affairs for Monsanto Corporation.
Michael A. Friedman, M.D. . . former acting commissioner of the United States Food and Drug Administration (FDA) Department of Health and Human Services . . .now senior vice-president for clinical affairs at G. D. Searle & Co., a pharmaceutical division of Monsanto Corporation.
L. Val Giddings . . . former biotechnology regulator and (biosafety) negotiator at the United States Department of Agriculture (USDA/APHIS), . . .now Vice President for Food & Agriculture of the Biotechnology Industry Organization (BIO).
Marcia Hale . . . former assistant to the President of the United States and director for intergovernmental affairs, . . .now Director of International Government Affairs for Monsanto Corporation.
Michael (Mickey) Kantor. . . former Secretary of the United States Department of Commerce and former Trade Representative of the United States, . . .now member of the board of directors of Monsanto Corporation.
Josh King . . . former director of production for White House events, ... now director of global communication in the Washington, D.C. office of Monsanto Corporation.
Terry Medley . . . former administrator of the Animal and Plant Health Inspection Service (APHIS) of the United States Department of Agriculture, former chair and vice-chair of the United States Department of Agriculture Biotechnology Council, former member of the U.S. Food and Drug Administration (FDA) food advisory committee, . . . and now Director of Regulatory and External Affairs of Dupont Corporation's Agricultural Enterprise.
Margaret Miller . . . former chemical laboratory supervisor for Monsanto, . . .now Deputy Director of Human Food Safety and Consultative Services, New Animal Drug Evaluation Office, Center for Veterinary Medicine in the United States Food and Drug Administration (FDA).*
Michael Phillips . . . recently with the National Academy of Science Board on Agriculture . . . now head of regulatory affairs for the Biotechnology Industry Organization.
William D. Ruckelshaus . . . former chief administrator of the United States Environmental Protection Agency (USEPA), . . .now (and for the past 12 years) a member of the board of directors of Monsanto Corporation.
Michael Taylor . . . former legal advisor to the United States Food and Drug Administration (FDA)'s Bureau of Medical Devices and Bureau of Foods, later executive assistant to the Commissioner of the FDA, . . . still later a partner at the law firm of King & Spaulding where he supervised a nine-lawyer group whose clients included Monsanto Agricultural Company, . . . still later Deputy Commissioner for Policy at the United States Food and Drug Administration, . . . and later with the law firm of King & Spaulding. . . . now head of the Washington, D.C. office of
Monsanto Corporation.*
Lidia Watrud . . . former microbial biotechnology researcher at Monsanto Corporation in St. Louis, Missouri, . . .now with the United States Environmental Protection Agency Environmental Effects Laboratory, Western Ecology Division.
Jack Watson. . .former chief of staff to the President of the United States, Jimmy Carter, . . .now a staff lawyer with Monsanto Corporation in Washington, D.C.
Clayton K. Yeutter . . . former Secretary of the U.S. Department of Agriculture, former U.S. Trade Representative (who led the U.S. team in negotiating the U.S. Canada Free Trade Agreement and helped launch the Uruguay Round of the GATT negotiations), now a member of the board of directors of Mycogen Corporation, whose majority owner is Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company.
Larry Zeph . . . former biologist in the Office of Prevention, Pesticides, and Toxic Substances, U.S. Environmental Protection Agency, . . . now Regulatory Science Manager at Pioneer Hi-Bred International.
*Margaret Miller, Michael Taylor, and Suzanne Sechen (an FDA "primary reviewer for all rbST and other dairy drug production applications" ) were the subjects of a U.S. General Accounting Office (GAO) investigation in 1994 for their role in the U.S. Food and Drug Administration's approval of Posilac, Monsanto Corporation's formulation of recombinant bovine growth hormone (rbST or rBGH). The GAO Office found "no conflicting financial interests with respect to the drug's approval" and only "one minor deviation from now superseded FDA regulations". (Quotations are from the 1994 GAO report).
---
"When people are trying to kill you and when they attack because they hate freedom, other disputes from Frankenfood to bananas and even important issues like the environment suddenly look a bit different." - Condoleezza Rice, George Bush's national security adviser
***********************************************************************
http://groups.yahoo.com/group/aspartameNM/message/927
Rumsfeld, 1977 head of Searle Corp., got aspartame FDA approval:
Turner: Murray 12.23.2 rmforall
http://groups.yahoo.com/group/aspartameNM/message/857
RTM: www.dorway.com: original documents and long reviews of flaws in
aspartame toxicity research 7.31.2 rmforall
http://www.dorway.com/upipart1.txt
UPI reporter Gregory Gordon: 96K 3-part expose Oct 1987
***********************************************************************
Your use of Yahoo! Groups is subject to http://docs.yahoo.com/info/terms/
|
